Small molecule MIRA-1 induces in vitro and in vivo anti-myeloma activity and synergizes with current anti-myeloma agents
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Small molecule MIRA-1 induces in vitro and in vivo anti-myeloma activity and synergizes with current anti-myeloma agents
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 110, Issue 9, Pages 2224-2231
Publisher
Springer Nature
Online
2014-04-02
DOI
10.1038/bjc.2014.164
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dual Targeting of Wild-Type and Mutant p53 by Small Molecule RITA Results in the Inhibition of N-Myc and Key Survival Oncogenes and Kills Neuroblastoma Cells In Vivo and In Vitro
- (2013) M. Burmakin et al. CLINICAL CANCER RESEARCH
- Targeting p53 by small molecules in hematological malignancies
- (2013) Manujendra N Saha et al. Journal of Hematology & Oncology
- PRIMA-1Met/APR-246 Displays High Antitumor Activity in Multiple Myeloma By Induction of p73 and Noxa
- (2013) Manujendra N. Saha et al. MOLECULAR CANCER THERAPEUTICS
- Addiction to c-MYC in multiple myeloma
- (2012) T. Holien et al. BLOOD
- Targeting p53 via JNK Pathway: A Novel Role of RITA for Apoptotic Signaling in Multiple Myeloma
- (2012) Manujendra N. Saha et al. PLoS One
- PRIMA-1Met/APR-246 induces wild-type p53-dependent suppression of malignant melanoma tumor growth in 3D culture and in vivo
- (2011) Wenjie Bao et al. CELL CYCLE
- Oncogenomics to Target Myeloma in the Bone Marrow Microenvironment
- (2011) Kenneth C. Anderson CLINICAL CANCER RESEARCH
- In Vitro and In Vivo Selective Antitumor Activity of a Novel Orally Bioavailable Proteasome Inhibitor MLN9708 against Multiple Myeloma Cells
- (2011) Dharminder Chauhan et al. CLINICAL CANCER RESEARCH
- Resveratrol Induces p53-independent, X-linked Inhibitor of Apoptosis Protein (XIAP)-mediated Bax Protein Oligomerization on Mitochondria to Initiate CytochromecRelease and Caspase Activation
- (2011) Raghu Gogada et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Molecular mechanisms of nutlin-induced apoptosis in multiple myeloma
- (2010) Manujendra N. Saha et al. CANCER BIOLOGY & THERAPY
- Rescue of the apoptotic-inducing function of mutant p53 by small molecule RITA
- (2010) Carolyn Y. Zhao et al. CELL CYCLE
- Emerging therapies for the treatment of relapsed or refractory multiple myeloma
- (2010) Meletios A. Dimopoulos et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- MDM2 antagonist can inhibit tumor growth in hepatocellular carcinoma with different types of p53 in vitro
- (2010) Jiabei Wang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- RITA Inhibits Multiple Myeloma Cell Growth through Induction of p53-Mediated Caspase-Dependent Apoptosis and Synergistically Enhances Nutlin-Induced Cytotoxic Responses
- (2010) M. N. Saha et al. MOLECULAR CANCER THERAPEUTICS
- Restoration of p53 to limit tumor growth
- (2009) Wenge Wang et al. CURRENT OPINION IN ONCOLOGY
- Pharmacological activation of the p53 pathway in haematological malignancies
- (2009) M. N Saha et al. JOURNAL OF CLINICAL PATHOLOGY
- Emerging Treatments for Multiple Myeloma: Beyond Immunomodulatory Drugs and Bortezomib
- (2009) Constantine S. Mitsiades et al. SEMINARS IN HEMATOLOGY
- Up-regulation of Mcl-1 Is Critical for Survival of Human Melanoma Cells upon Endoplasmic Reticulum Stress
- (2008) C. C. Jiang et al. CANCER RESEARCH
- PRIMA-1met radiosensitizes prostate cancer cells independent of their MTp53-status
- (2008) Stéphane Supiot et al. RADIOTHERAPY AND ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now